OnKure Therapeutics Inc. Class A Company Profile
NASDAQ: OKURHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 2.40 -0.41%
OnKure Therapeutics at a glance
OnKure Therapeutics Inc. Class A (NASDAQ: OKUR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boulder, CO. OnKure Therapeutics is led by Dr. Nicholas A. Saccomano Ph.D. and employs about 45 people. The company's shares have traded publicly since 2021.
At a market capitalization of $93.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001637715, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does OnKure Therapeutics do?
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Business description based on the company's public filings.
Company information
- Legal name
- OnKure Therapeutics Inc. Class A
- Ticker
- NASDAQ: OKUR
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Nicholas A. Saccomano Ph.D.
- Employees
- 45
- Headquarters
- 6707 Winchester Circle, Boulder, CO, United States
- Phone
- 720-307-2892
- Website
- onkuretherapeutics.com
- IPO year
- 2021
- Market cap
- $93.14M
- SEC CIK
- 0001637715
- Latest annual report
- 10-K · Mar 12, 2026
Companies similar to OnKure Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MISTMilestone Pharmaceuticals Inc. | 0.765 | +7.43% | $95.24M | vs OKUR |
| RLYBRallybio Corporation | 17.02 | +0.18% | $90.42M | vs OKUR |
| EQEquillium Inc. | 1.41 | -2.08% | $89.41M | vs OKUR |
| CTORCitius Oncology Inc. | 0.8398 | +0.57% | $88.82M | vs OKUR |
| PLYXPolaryx Therapeutics Inc. | 2.00 | 0.00% | $99.69M | vs OKUR |
| PDSBPDS Biotechnology Corporation | 1.38 | +35.29% | $100.01M | vs OKUR |
| PMNProMIS Neurosciences Inc. | 9.61 | +5.03% | $86.18M | vs OKUR |
| ANIXAnixa Biosciences Inc. | 2.90 | -0.34% | $100.82M | vs OKUR |